Eri Arita

472 total citations
10 papers, 399 citations indexed

About

Eri Arita is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Eri Arita has authored 10 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Eri Arita's work include Cholesterol and Lipid Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Eri Arita is often cited by papers focused on Cholesterol and Lipid Metabolism (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). Eri Arita collaborates with scholars based in Japan, Netherlands and United States. Eri Arita's co-authors include Taichi Sugizaki, Hiroshi Itoh, Yasushi Horai, Kohkichi Morimoto, Mitsuhiro Watanabe, Kristina Schoonjans, Sander M. Houten, Chikage Mataki, Johan Auwerx and Hiroyuki Sato and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Eri Arita

10 papers receiving 397 citations

Peers

Eri Arita

ONCOL

EPIDE

SURGE

PHYSI

Judi A. McNulty United States

Dariusz Belowski Poland

Marina Rousseau Canada

Christine Cugnet‐Anceau France

Kazutaka Tanabe Japan

Simona Stan Canada

Andreas Brønden Denmark

Anna Duława Poland

Katalin Jármay Hungary

Zhongjie Zhou China

Judi A. McNulty United States

Eri Arita

134 ×0.8

ONCOL

134 ×1.0

EPIDE

118 ×0.9

SURGE

159 ×1.4

98 ×1.0

PHYSI

Citations per year, relative to Eri Arita Eri Arita (= 1×) peers Judi A. McNulty

Countries citing papers authored by Eri Arita

Since Specialization

Citations

This map shows the geographic impact of Eri Arita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Arita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Arita more than expected).

Fields of papers citing papers by Eri Arita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eri Arita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Arita. The network helps show where Eri Arita may publish in the future.

Co-authorship network of co-authors of Eri Arita

This figure shows the co-authorship network connecting the top 25 collaborators of Eri Arita. A scholar is included among the top collaborators of Eri Arita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eri Arita. Eri Arita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Till, J. W. Olivier van, Eri Arita, Richard Croy, et al.. (2022). Muscarinic‐3‐receptor positive allosteric modulator ASP8302 in patients with underactive bladder. A randomized controlled trial. Neurourology and Urodynamics. 41(5). 1139–1148. 7 indexed citations

Kanba, Shigenobu, et al.. (2019). Long-term mood/antidepressant effects of quetiapine extended-release formulation: an open-label, non-controlled extension study in Japanese patients with bipolar depression. BMC Psychiatry. 19(1). 198–198. 10 indexed citations

Murasaki, Mitsukuni, et al.. (2018). Multi-center, randomized, double-blind, placebo-controlled study of quetiapine extended-release formulation in Japanese patients with bipolar depression. Psychopharmacology. 235(10). 2859–2869. 26 indexed citations

Sugizaki, Taichi, Mitsuhiro Watanabe, Yasushi Horai, et al.. (2014). The Niemann-Pick C1 Like 1 (NPC1L1) Inhibitor Ezetimibe Improves Metabolic Disease Via Decreased Liver X Receptor (LXR) Activity in Liver of Obese Male Mice. Endocrinology. 155(8). 2810–2819. 27 indexed citations

Watanabe, Mitsuhiro, Kohkichi Morimoto, Sander M. Houten, et al.. (2012). Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure. PLoS ONE. 7(8). e38286–e38286. 95 indexed citations

Watanabe, Mitsuhiro, Yasushi Horai, Sander M. Houten, et al.. (2011). Lowering Bile Acid Pool Size with a Synthetic Farnesoid X Receptor (FXR) Agonist Induces Obesity and Diabetes through Reduced Energy Expenditure. Journal of Biological Chemistry. 286(30). 26913–26920. 212 indexed citations

Ono, Takeshi, Akihiro Muto, Toshio Kaneda, Eri Arita, & Tadashi Yoshida. (2009). Novel Linkage Disequilibrium of Single Nucleotide Polymorphisms in the Transcriptional Regulatory Region of .MU.-Opioid Receptor Gene in Japanese Population. Biological and Pharmaceutical Bulletin. 32(4). 721–723. 7 indexed citations

Arita, Eri, Masuo Kondoh, Katsuhiro Isoda, et al.. (2008). Evaluation of promoter strength in mouse and rat primary hepatocytes using adenovirus vectors. European Journal of Pharmaceutics and Biopharmaceutics. 70(1). 1–6. 7 indexed citations

Isoda, Katsuhiro, Eri Arita, Midori Kojima, et al.. (2006). Protection against CCl4-induced injury in liver by adenovirally introduced thioredoxin gene. Biochemical and Biophysical Research Communications. 350(1). 157–161. 3 indexed citations

10.

Isoda, Katsuhiro, Midori Kojima, Eri Arita, et al.. (2005). Stimulation of hepatocyte survival and suppression of CCl4-induced liver injury by the adenovirally introduced C/EBPβ gene. Biochemical and Biophysical Research Communications. 329(1). 182–187. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact